The transdifferentiation of adipose-derived mesenchymal stem cells (ADMSCs) into insulin-producing cells (IPCs) is a potential resource for the treatment of diabetes. However, the changes of genes and
Transcript levels and CpG island methylation of bivalent genes Nestin (A,B) and Sox1 (C,D) as well as the non-bivalent gene Tet1 (E,F) in undifferentiated ESCs (day 0) and at day 4 and 16 of EB cultur